Template to add a clinical trial: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:


== Inclusion Criteria ==
== Inclusion Criteria ==
None reported
 
PATIENTS:
PATIENTS:



Revision as of 18:59, 2 June 2009

WikiDoc Resources for Template to add a clinical trial

Articles

Most recent articles on Template to add a clinical trial

Most cited articles on Template to add a clinical trial

Review articles on Template to add a clinical trial

Articles on Template to add a clinical trial in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Template to add a clinical trial

Images of Template to add a clinical trial

Photos of Template to add a clinical trial

Podcasts & MP3s on Template to add a clinical trial

Videos on Template to add a clinical trial

Evidence Based Medicine

Cochrane Collaboration on Template to add a clinical trial

Bandolier on Template to add a clinical trial

TRIP on Template to add a clinical trial

Clinical Trials

Ongoing Trials on Template to add a clinical trial at Clinical Trials.gov

Trial results on Template to add a clinical trial

Clinical Trials on Template to add a clinical trial at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Template to add a clinical trial

NICE Guidance on Template to add a clinical trial

NHS PRODIGY Guidance

FDA on Template to add a clinical trial

CDC on Template to add a clinical trial

Books

Books on Template to add a clinical trial

News

Template to add a clinical trial in the news

Be alerted to news on Template to add a clinical trial

News trends on Template to add a clinical trial

Commentary

Blogs on Template to add a clinical trial

Definitions

Definitions of Template to add a clinical trial

Patient Resources / Community

Patient resources on Template to add a clinical trial

Discussion groups on Template to add a clinical trial

Patient Handouts on Template to add a clinical trial

Directions to Hospitals Treating Template to add a clinical trial

Risk calculators and risk factors for Template to add a clinical trial

Healthcare Provider Resources

Symptoms of Template to add a clinical trial

Causes & Risk Factors for Template to add a clinical trial

Diagnostic studies for Template to add a clinical trial

Treatment of Template to add a clinical trial

Continuing Medical Education (CME)

CME Programs on Template to add a clinical trial

International

Template to add a clinical trial en Espanol

Template to add a clinical trial en Francais

Business

Template to add a clinical trial in the Marketplace

Patents on Template to add a clinical trial

Experimental / Informatics

List of terms related to Template to add a clinical trial

How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections. More help to add a trial here.


European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

Study Acronym (The trial's abbreviation if there is one)

None reported

Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K; EUROTRANSFER Registry Investigators.

BACKGROUND: Abciximab is established as adjunct to primary percutaneous coronary intervention (PCI). Based on some smaller studies, ST-segment elevation myocardial infarction (STEMI) networks in various European countries have adopted the start of abciximab before transfer to the catheterization laboratory (cathlab) hospital as part of their routine treatment options. Although a recently published study did not reveal improved clinical outcome when starting abciximab before the cathlab, a potential benefit from such early administration, in particular in the setting of transfer networks, remains unclear and has been the subject of debate.

Patients with ST-Elevation MI

Study Phase (e.g. Phase I,II,III,IV) Study Phases are defined here

None reported

Natural History, Cross-Sectional, Defined Population, Prospective Study

Study Arms and How They Were Treated (Intervention) (Explanation here)

None reported

Primary Pre-Specified Endpoint

None reported

Secondary Endpoints

None reported

Inclusion Criteria

PATIENTS:

All consecutive STEMI patients >=18years arriving to the Cath Lab hospital (invasive facility center) from transfer.

Transfer with respect to this registry is defined as patients that reach the Cath Lab hospital:

transferred from a surrounding regional community hospitals that the Cath Lab hospital has an established referral pattern with or after being picked–up by an ambulance which is equipped/staffed to provide specific medical therapy (like prehospital thrombolysis or upstream abciximab). Usually these have a physician or specifically trained nurse on board.

Exclusion Criteria

None reported

Outcome: Primary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Secondary endpoint (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Exploratory endpoints (Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)

None reported

Outcome: Safety endpoints (Report both relative risk and absolute risk as well as number needed to harm if available)

None reported

Conclusions of the Investigators (Quote the investigators conclusions here)

None reported

Commentary, Discussion and Limitations of the Trial (Anyone can add comments)

None reported

Slides

None reported

Video Commentary

None reported

References (How to insert a reference)

None reported

External sites for further information (How to insert links)

None reported

Detailed information about the trial

Ages

__ years to ___ years

Gender (Indicate whether men, women or both were enrolled)

None reported

Accepts Healthy Volunteers (Answer yes or no)

None reported

Enrollment Period (Study start and end date)

None reported

Recruitment Status (explanation)

None reported

Enrollment (Total number of patients enrolled)

None reported

Study Sponsor (e.g. Investigator initiated or company name)

None reported (this may not have yet been ascertained)

Source of Data (Where is this data on this page coming from: publication, principal investigator, or co-investigator)

None reported


The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.

Template:WH

Template:WS